Eli Lilly and Company is a leading pharmaceutical firm with a global reputation for developing and marketing innovative medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, the compa... Eli Lilly and Company is a leading pharmaceutical firm with a global reputation for developing and marketing innovative medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, the company operates within the pharmaceuticals and biotechnology sector, addressing a wide spectrum of diseases through prescription drugs and biopharmaceutical products. Eli Lilly’s research and development efforts have produced treatments in areas such as oncology, endocrinology (notably diabetes care), immunology, neuroscience, and rare diseases, making it a key player in improving patient outcomes across multiple therapeutic segments. The company's large scale is reflected in its substantial market capitalization, its listing on major exchanges, and its presence in over 120 countries. Eli Lilly’s continued investment in clinical research and strategic collaborations underscores its pivotal role in driving advancements within the pharmaceutical industry, impacting both healthcare systems and patients worldwide.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Eli Lilly and Co is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Eli Lilly and Co is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Eli Lilly and Co's data?

Create a free Tracenable account to signal interest in having our team review data for Eli Lilly and Co.

Legal Center Contact Us